Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Tsong‐Hai Lee(Chang Gung University), Craig S. Anderson(Royal Prince Alfred Hospital), Laurent Billot(The George Institute for Global Health), Christopher Levi(John Hunter Hospital), Andrew M. Demchuk(University of Calgary), Xia Wang(University of Leicester), Pablo M. Lavados(University of Leicester), Octávio Marques Pontes‐Neto(Universidade de São Paulo), Vijay K. Sharma(Cornell University), Geoffrey A. Donnan(The Royal Melbourne Hospital), Qiang Li(Chinese Academy of Sciences), Sheila Cristina Ouriques Martins(Universidade Federal do Rio Grande do Sul), Candice Delcourt(University of Leicester), Mark Woodward(UNSW Sydney), Stefano Ricci(Città di Castello Hospital), Thompson Robinson(University of Leicester), Alice C. Durham(University of Leicester), Verónica V. Olavarría(Universidad del Desarrollo), Lili Song(Tongji University), Richard I. Lindley(Westmead Hospital), Jeyaraj Pandian(Christian Medical College, Vellore), Philip M. Bath(Nottingham University Hospitals NHS Trust), Joseph P. Broderick(University of Cincinnati), Federico Silva(The George Institute for Global Health), Mark Parsons(UNSW Sydney), Hisatomi Arima(University of Leicester), Shoichiro Sato(National Cerebral and Cardiovascular Center), Xiaoying Chen(The University of Sydney), Guofang Chen(Xuzhou Central Hospital), Yining Huang(Nanjing University of Chinese Medicine), Ji-Guang Wang(Shanghai Institute of Hypertension), Joanna M. Wardlaw(University of Edinburgh), Tsong-Hai Lee(Chang Gung University)
The Lancet
February 9, 2019
Cited by 271


Related Papers